Kidney Week 2021 Hyperuricemia In-Depth

Higher Uric Acid in Inpatient COVID-19 Cases Ups AKI Risk

By

Jody A. Charnow

Patients with COVID-19 who had the highest quartile of serum uric acid at hospital admission had increased odds of acute kidney injury.

Gout Common in the US Dialysis Population

By

Jody A. Charnow

New analysis suggests that gout prevalence is 21% among patients on peritoneal dialysis and 13% among those on hemodialysis.

Urate-Lowering Therapy Not Renoprotective When Kidney Function is Normal

By

Jody A. Charnow

New findings complement previous research showing no renoprotective effect of urate-lowering therapy in patients with chronic kidney disease.

Pegloticase Effective for Uncontrolled Gout in Kidney Transplant Recipients

By

Jody A. Charnow

In a study of kidney transplant recipients treated with pegloticase for uncontrolled gout, the proportion of patients experiencing gout flares declined over the treatment period.

Gout Risk Factors, Outcomes in Dialysis Population Characterized

By

Jody Charnow

Some 15% of patients receiving dialysis in the United States have a gout diagnosis, according to a recent study.